Trials / Conditions / Clopidogrel, Poor Metabolism of

Clopidogrel, Poor Metabolism of

8 registered clinical trials studyying Clopidogrel, Poor Metabolism of — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA) NCT05566301	IRCCS Policlinico S. Donato	—
Unknown	Aggregometry in Elderlies With Hip Fracture and Receiving Clopidogrel NCT04642209	University Magna Graecia	—
Completed	CES1 Carriers in the PAPI Study NCT03188705	University of Maryland, Baltimore	Phase 4
Unknown	Clopidogrel Resistance in Stroke Patients From Different Ethnicities NCT03806894	Ziv Hospital	—
Terminated	The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions NCT04007055	Marissa Jarosinski	Phase 3
Unknown	Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidog NCT03062462	First Affiliated Hospital of Harbin Medical University	Phase 2 / Phase 3
Completed	Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease NCT03174990	University of California, Davis	—
Completed	PTRG-DES Consortium NCT04734028	Gyeongsang National University Hospital	—